A multinational pharmaceutical and biotechnology company here has introduced a medical breakthrough that could provide therapeutic options to patients with Parkinson’s Disease.

BMS is exiting the first U.S.-China pharmaceutical joint venture. Kalexo Bio and Ollin Biosciences have launched with big ...

The company said it will address the observations and respond to the FDA within the stipulated timeframe, reaffirming its ...

Learn more about whether Alnylam Pharmaceuticals, Inc. or Roivant Sciences Ltd. is a better investment based on AAII's A+ ...

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is one of the best affordable biotech stocks to invest in now. Rigel ...

Innovative Pharmaceutical Biotech ( ($HK:0399) ) just unveiled an announcement. Innovative Pharmaceutical Biotech Limited has announced a further ...

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is one of the best affordable biotech stocks to invest in now . Rigel ...

The FDA cracks down on deceptive drug advertising, targeting major pharma and telehealth firms. Read more here.

Outlining the key touchpoints for embracing change and opportunity in the “messy, tough—and fun” R&D-to-commercial transition ...

Swiss pharmaceutical giant Roche has agreed to acquire US biotech firm 89bio, a developer of therapies for liver and cardiometabolic diseases, in a transaction valued at up to about $3. 5 billion.

Funds from the US are flowing into biotech ETFs as investors seek unique opportunities to beat the market, China AMC’s Heidi Cai says.